Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells

Abstract

Abstract: Objective To investigate the cleavage of telomerase RNA component (hTR) by two DNAzymes and their effects on the expression of two apoptosis-related genes in a human mammary cancer cell line (MCF-7). Methods Two "10-23" DNAzymes (DzT and DzTi) targeted against hTR RNA and their analogues (DzT’ and DzTi’) were synthesized and used to cleave hTR RNA in vitro and in MCF-7 cells. Reverse transcriptional (RT) PCR amplification of a hTR DNA fragment and telomerase activity assay by PCR-enzyme-linked immunosorbent assay (ELISA) were performed to assess the cleavage efficiency. The biological effect of the DNAzymes was evaluated by measuring the expression of two apoptosis-related genes (bax-2 and bax). Results The unmodified DNAzyme, DzT, and its modified form, DzTi, which had an 3’-inverted thymidine added, could effectively cleave hTR mRNA in vitro. After transfection into MCF-7 cells, DzTi exhibited more powerful cleavage ability than DzT, and down-regulated the activity of telomerase (P<0.05). However, neither DzTi nor DzT displayed significant effect on the growth of the cells (P>0.05) and the expression of bax-2 and bax (P>0.05). DzT’ and DzTi’, derived from DzT and DzTi respectively with a base displacement in the conserved catalytic motif, did not exhibit notable cleavage effect on hTR RNA either in vitro or in the cells. Conclusion The synthesized DNAzymes can effectively and specifically cleave hTR RNA and decrease the telomerase activity. As a newly found catalytic nucleic acid, DNAzymes will play an important role in gene therapy studies of tumors.

CLC Number:

R737.9
Q523

ZHAO Jia-ming¹, LI Ming-yi², YANG Zhan¹, LI Zhen¹, ZHANG Yi¹. Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells[J]. Journal of Southern Medical University, 2005, 25(06): 638-642.

References

[1] Santoro SW, Joyce GF. Mechanism and utility of an RNA-cleaving DNA enzyme[J]. Biochemistry, 1998, 37(38):13330-42.
[2] Goila R, Banerjea AC. Inhibition of hepatitis B virus X gene expression by novel DNA enzymes[J]. Biochem J, 2001, 353(Pt 3):701-8.
[3] Santiago FS, Lowe HC, Kavurma MM, et al. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury[J]. Nat Med, 1999, 5(11):1264-9.
[4] Breaker RR, Joyce GF. A DNA enzyme that cleaves RNA[J]. Chem Biol, 1994, 1(4):223-39.
[5] Sun LQ, Cairns M J, Gerlach WL, et al. Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme [J].J Biol Chem, 1999, 274(24):17236-41.
[6] Mitchell A, Dass CR, Sun LQ, et al. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1 [J]. Nucleic Acids Res, 2004, 32(10):3065-9.
[7] 于乐成,顾长海,王升启,等.HCV脱氧核酶在表达荧光素酶HepG2细胞中的活性[J].第三军医大学学报,2003,25(10):870-3.Yu YC, Gu CH, Wang SQ, et al. Activity of specific deoxyribozymes targeting at HCV 5′-NCR controlling luciferase expression in transfected HepG2 cells[J]. Di-San Jun Yi Da Xue Xue Bao, 2003,25(10):870-3.
[8] 沃健儿,吴晓玲,朱海红,等.脱氧核酶抑制乙型肝炎病毒基因表达的实验研究[J].浙江大学学报(医学版),2003,32(2):112-5.
[9] Lowe HC, Fahmy RG, Kavurma MM, et al. Catalytic oligodeoxynucleotides define a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis [J].Circ Res, 2001, 89(8):670-7.
[10] Herbert B, Pitts AE, Baker SI, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death [J]. Proc Natl Acad Sci USA, 1999, 96 (25):14276-81.

[1]	LI Xin-an,AN Jing Department of Embryology and Histology,Southern Medical University,Guangzhou 510515,China. Mechanisms of the expression of exogenous genes injected via the mammary duct in rat mammary gland tissue [J]. Journal of Southern Medical University, 2006, 26(12): 1774-.
[2]	WU Wu-jun1,ZENG Jian2,PAN Cheng-en1 1Department of General Surgery,First Hospital of Xi’an Jiaotong University,Xi’an 710061,China;2Department of Gastrointestinal and Glands Surgery,First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China. Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis [J]. Journal of Southern Medical University, 2006, 26(12): 1812-1814.
[3]	KANG Hua-feng,WANG Xi-jing,LIU Xiao-xu,DAI Zhi-jun,XUE Feng-jie,XUE Xing-huan Department of Oncological Surgery,Second Affiliated Hospital,School of Medicine,Xi’an Jiaotong University,Xi’an 710004,China. Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism [J]. Journal of Southern Medical University, 2006, 26(11): 1599-1602.
[4]	LI Gui-ping1, ZHANG Yi-fan2, WANG Yong-xian3 1Departmant of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; 2Department of Nuclear Medicine, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China; 3Radiopharmaceutical Research Center, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China. 188Re-labeled herceptin inhibits proliferation of breast cancer cell line SKBR-3 in vitro [J]. Journal of Southern Medical University, 2006, 26(10): 1455-1457.
[5]	. [J]. Journal of Southern Medical University, 2006, 26(09): 1378-1379.
[6]	WANG Xiao-yu1, LIN Shao-qiang2, LI Jun-wu2, Kemmner Wolfgang3, DING Yan-qing4 Department of Obstetrics and Gynecology, First Affiliated Hospital of Ji’nan University1, Department of Microbiology and Immunology of Medical College2, Jinan University, Guangzhou 510630, China; 3Max-Delbrueck Center for Molecular Medicine,Berlin 13125, Germany; 4Institute of Oncology, Southern Medical University, Guangzhou 510515, China. Effect of cell surface sialic acid and their linkages on adhesion of mammary carcinoma cells [J]. Journal of Southern Medical University, 2006, 26(06): 742-746.
[7]	WANG Xiao-bing, YANG Qing-xu, PEI Xiao-juan Department of Pathology, Huizhou Central Hospital, Huizhou 516001, China. Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance [J]. Journal of Southern Medical University, 2006, 26(06): 860-863.
[8]	HU Xiao-qu1,QIN Li1,SU Feng-xi1,YAO He-rui2,CHEN Ji-sheng1,GONG Chang1,GUO Ju-jiang1,YU Feng-yan1,JIA Hai-xia1 1Center of Breast Cancer,2Department of Oncology,Second Hospital of Sun Yat-sen University,Guangzhou 510272,China. Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer [J]. Journal of Southern Medical University, 2006, 26(05): 570-572.
[9]	ZHANG Shu-qun1,ZHANG Shu-hui2,XUE Xin-huan1,WANG Xi-jing1,JIANG Jian-tao1 1Department of Oncology,Second Hospital,Xi’an Jiaotong University,Xi’an 710004,China;2Department of Chemical Engineering,Northwestern Polytechnical University,Xi’an 710072,China. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro [J]. Journal of Southern Medical University, 2006, 26(03): 251-254.
[10]	FAN Yi-xiang,LUO Rong-Cheng,FANG Yong-Xin,YAN Xiao,Department of Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China. Preparation,quality control and biodistribution of 131I-herceptin in New Zealand rabbits [J]. Journal of Southern Medical University, 2006, 26(03): 361-.
[11]	XU Lei, BAI Zhong-hong, XU Ruan-cheng, YAN Hui, WANG Fang-ju, LUO Rong-cheng Department of Oncology, 91 Hospital of PLA, Jiaozuo 454003, China;Oncology Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Expressions of Her-2, EGFR, PS-2 and ER in breast cancer and their clinical implications [J]. Journal of Southern Medical University, 2006, 26(02): 231-233.
[12]	TAN Ke, FAN Yi-xiang, MIAO Jing-xia, L(?) Cheng-wei, YAN Xiao, LUO Rong-cheng Center of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Killing effect of sequential Herceptin and adriamycin treatment on breast cancer cell line in vitro [J]. Journal of Southern Medical University, 2006, 26(02): 234-236.
[13]	CUI Fei, LUO Rong-cheng, CHEN Jin-zhang, CHEN Bin, HUANG Yu-xian. Therapeutic effect of TAX combined with Herceptin or epirubicin against breast cancer positive for Her-2/neu [J]. Journal of Southern Medical University, 2005, 25(12): 1533-1536.
[14]	LI Rong, ZHENG Hang, LUO Rong-cheng. Cloning and expression of the HER2 gene in MCF-7 cells [J]. Journal of Southern Medical University, 2005, 25(10): 1264-1267.
[15]	ZHENG Hang, LUO Rong-cheng. Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer [J]. Journal of Southern Medical University, 2005, 25(10): 1293-1294,1298.